DocDollars

C. R. Bard, Inc. & Subsidiaries

NJ · United States · Reporting entity ID 100000000057

Total reported 2019–2025
$12.2M
#437 of 2,960 reporting companies — 0% of all reported industry payments
$5.29M in general payments across 13,587 records, plus $6.93M in research funding across 296 records.

How it breaks down

General payments $5,289,186
Research funding $6,928,869

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

C. R. Bard, Inc. & Subsidiaries reported $12.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #437 of 2,960 reporting companies. 57% of that was research funding and 43% general payments such as consulting, speaking, food and travel. 13,587 general payment records and 296 research records were filed.

Common questions about C. R. Bard, Inc. & Subsidiaries

How much has C. R. Bard, Inc. & Subsidiaries paid US doctors?

C. R. Bard, Inc. & Subsidiaries reported $12,218,055 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $5,289,186 in general payments, $6,928,869 in research funding.

How does C. R. Bard, Inc. & Subsidiaries rank among drug and device companies?

It ranks #437 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from C. R. Bard, Inc. & Subsidiaries mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.